How to Get Affordable Insulin: Programs, Caps, and Options

Insulin prices have been a crisis for millions. Federal caps, manufacturer programs, and pharmacy options have changed the landscape. Here's the current picture.

Insulin affordability has been a crisis in America for years. People with diabetes have rationed doses, driven to Canada, and started GoFundMe campaigns to pay for a drug that's been available for over a century. But the landscape has shifted significantly. Federal price caps, manufacturer pricing commitments, and new pharmacy options have created real savings — if you know where to find them.

The Federal Insulin Price Cap

The Inflation Reduction Act capped the out-of-pocket cost of insulin at $35 per month for Medicare Part D and Medicare Advantage enrollees. This applies to all covered insulin products — pens, vials, and biosimilars — regardless of the plan's formulary tier. If you're on Medicare and paying more than $35 per month for insulin, contact your plan immediately.

The $35 cap applies specifically to Medicare. Commercial insurance and uninsured patients aren't covered by the federal cap, though many states have enacted their own insulin price caps for commercial plans.

Manufacturer Pricing Commitments

All three major insulin manufacturers — Eli Lilly, Novo Nordisk, and Sanofi — have made significant pricing changes. Eli Lilly capped the out-of-pocket cost of its insulin products at $35 per month for people with commercial insurance and created programs for uninsured patients. Novo Nordisk and Sanofi made similar commitments. These programs vary in eligibility and duration, so check each manufacturer's website for current details.

Several biosimilar insulins have also entered the market, providing additional competition and lower prices. Biosimilars are the biological equivalent of generic drugs — they're made to be highly similar to the original brand-name insulin and are approved by the FDA through a rigorous process.

Patient Assistance Programs for Insulin

All major insulin manufacturers offer patient assistance programs that provide free insulin to qualifying uninsured patients. Income eligibility thresholds are typically at or below 400% of the federal poverty level. Applications require documentation of income and insurance status and are usually processed within a few weeks. These programs are underutilized — many eligible patients don't know they exist or assume they won't qualify.

Pharmacy Options

Cost Plus Drugs does not currently carry insulin, but other direct-to-consumer and mail-order pharmacies may offer competitive pricing. Amazon Pharmacy shows transparent insulin pricing for Prime members. And Costco pharmacies typically offer lower insulin prices than chain pharmacies.

For patients with commercial insurance, the cheapest option depends on your plan's formulary. Always check which insulin products are on your plan's preferred tier — switching from a non-preferred to a preferred insulin (with your doctor's approval) can dramatically reduce your copay.

If You're Struggling Right Now

If you're rationing insulin or unable to afford your next fill, resources are available today. Call your insulin manufacturer's patient assistance line — they can often expedite emergency supplies. Visit a federally qualified health center (FQHC), which may have 340B-priced insulin available immediately. And ask your doctor about samples — many clinics keep insulin samples from manufacturer representatives and can provide a short-term supply while your assistance application is processed.

No one should go without insulin because of cost. The programs and price caps that exist today aren't perfect, but they represent real savings that millions of people are eligible for. Search your insulin on RxGator to see pricing across all available sources.